Delaware AI Healthcare Regulations: A Comprehensive Guide

Delaware does not have a standalone AI healthcare statute. Compliance depends on federal frameworks (FDA, HIPAA) applied alongside existing Delaware medical practice, data privacy, and consumer protection laws.

Quick Answer: Current State of AI Healthcare Regulation in Delaware

Delaware healthcare providers using AI tools are not subject to a specific state statute governing AI in healthcare. Instead, a combination of existing laws applies.

Federally, the FDA regulates AI software that meets the definition of a medical device. HIPAA governs AI systems that handle protected health information (PHI). At the state level, Delaware's medical licensure board, health information privacy statute, consumer protection law, and general malpractice principles apply to AI-assisted care, even though they do not explicitly mention AI.

This absence of specific AI legislation is not a loophole. Regulators and courts will apply existing standards to AI-related conduct. Providers who assume that the lack of AI-specific law means there is no AI-specific liability risk face serious consequences.

Delaware's General Assembly has not passed comprehensive AI healthcare legislation. Consult the Delaware General Assembly's bill search portal (legis.delaware.gov) for pending proposals, as this regulatory area is rapidly evolving nationwide.

Federal vs. State Oversight: Navigating AI in Delaware Healthcare

FDA Authority Over AI as a Medical Device

The FDA regulates artificial intelligence and machine learning tools that qualify as Software as a Medical Device (SaMD). The agency's "Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device Action Plan" (FDA, January 2021) and subsequent guidance on predetermined change control plans define when software